Discovery and Optimization of Biaryl Alkyl Ethers as a Novel Class of Highly Selective, CNS-Penetrable, and Orally Active Adaptor Protein-2-Associated Kinase 1 (AAK1) Inhibitors for the Potential Treatment of Neuropathic Pain

Author:

Luo Guanglin1ORCID,Chen Ling1,Kostich Walter A.2,Hamman Brian3,Allen Jason3,Easton Amy2,Bourin Clotilde2,Gulianello Michael2,Lippy Jonathan4,Nara Susheel5,Pattipati Sreenivasulu Naidu5,Dandapani Kumaran5,Dokania Manoj5,Vattikundala Pradeep5,Sharma Vivek5,Elavazhagan Saravanan5,Verma Manoj Kumar5,Lal Das Manish5,Wagh Santosh5,Balakrishnan Anand6,Johnson Benjamin M.6ORCID,Santone Kenneth S.6,Thalody George7,Denton Rex7,Saminathan Hariharan5,Holenarsipur Vinay K.5,Kumar Anoop5,Rao Abhijith5,Putlur Siva Prasad5,Sarvasiddhi Sarat Kumar5,Shankar Ganesh5,Louis Justin V.5,Ramarao Manjunath5,Conway Charles M.2,Li Yu-Wen2,Pieschl Rick2,Tian Yuan2,Hong Yang2,Bristow Linda2,Albright Charles F.2,Bronson Joanne J.1,Macor John E.1,Dzierba Carolyn D.1

Affiliation:

1. Department of Neuroscience Chemistry, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States

2. Department of Neuroscience Discovery Biology, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States

3. Lexicon Pharmaceuticals, 8800 Technology Forest Place, The Woodlands, Texas 77381, United States

4. Department of Lead Evaluation, Bristol Myers Squibb Company, Route 206 & Province Line Rd, Princeton, New Jersey 08543, United States

5. Biocon-Bristol Myers Squibb Research and Development Centre, Biocon Park, Plot No. 2 & 3, Bommasandra Phase IV, Jigani Link Road, Bangalore 560099, India

6. Department of Pharmaceutical Candidate Optimization, Bristol Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States

7. Discovery Toxicology, Bristol Myers Squibb Company, Route 206 & Province Line Rd, Princeton, New Jersey 08543, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3